VWA
HRMY icon

Valued Wealth Advisors’s Harmony Biosciences HRMY Stock Holding History

Valued Wealth Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.8K Buy
351
+74
+27% +$2.33K ﹤0.01% 268
2026
Q1 		$7.76K Buy
+277
New +$9.08K ﹤0.01% 329

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Valued Wealth Advisors's HRMY Position: Q2 2026 in Review

Valued Wealth Advisors increased its Harmony Biosciences (HRMY) stake by 27% in Q2 2026, buying an estimated $2.33K and bringing the position to 351 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #268.

Valued Wealth Advisors first reported a position in HRMY in Q1 2026 and has held it in 2 quarters since. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Valued Wealth Advisors held 351 shares of Harmony Biosciences worth $12.8K as of Q2 2026.
  • Valued Wealth Advisors bought 74 Harmony Biosciences shares in Q2 2026, an estimated $2.33K.
  • Harmony Biosciences made up ﹤0.01% of Valued Wealth Advisors's portfolio in Q2 2026, its #268 holding.
  • Valued Wealth Advisors first reported a position in Harmony Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Valued Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.